XML 57 R42.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Expense for Employees and Non-Employees
The following table presents total share-based compensation expense recorded (in thousands):
 Years Ended December 31,
 202420232022
Cost of revenues$1,786 $2,256 $2,484 
Research and development28,044 44,103 41,335 
Sales and marketing7,466 9,524 13,857 
General and administrative47,318 77,619 75,780 
Total share-based compensation expense$84,614 $133,502 $133,456 
Schedule of Assumptions Used to Determine Fair Value of ESPP
The following table presents the key assumptions used to determine the fair value of the awards:

Expected term (years)3.00
Expected volatility49.04 %
Expected dividends— %
Risk-free interest rate0.27 %
The following table presents the key assumptions used to determine the fair value of rights granted under the ESPP:
 Years Ended December 31,
 202420232022
Expected term (years)0.500.500.50
Expected volatility
60.95%-85.39%
55.79%-109.39%
70.37%-78.74%
Dividend yield0.00 %0.00 %0.00 %
Risk-free interest rate
4.44%-5.40%
5.24%-5.41%
1.54%-4.54%
Weighted-average grant-date fair value per share$0.90 $3.62 $8.71 
Schedule of Restricted Stock Unit and Performance Share Unit Activity
RSUs and PSUs Activity
 Number of RSUs and PSUs OutstandingWeighted Average Grant Date Fair Value
Balance at December 31, 202310,065,783 $23.63 
Granted5,853,240 4.24 
Released(5,069,408)21.02 
Forfeited(3,462,650)22.50 
Balance at December 31, 20247,386,965 $10.58 
Schedule of Stock Option Activity
Stock Option Activity
 
Number of Stock Options Outstanding
Weighted-Average Exercise Price per ShareWeighted-Average Remaining Contractual Term in YearsAggregate Intrinsic Value
Balance at December 31, 2023232,327 $6.02 1.81$1,240,014 
Forfeited(50,251) 
Balance at December 31, 2024182,076 $5.74 1.17$—